Prenetics Global (PRE) News Today $5.42 +0.07 (+1.21%) Closing price 02/21/2025 03:57 PM EasternExtended Trading$5.55 +0.14 (+2.49%) As of 02/21/2025 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period PositiveID (OTCMKTS:PSID) & Prenetics Global (NASDAQ:PRE) Critical ReviewFebruary 20 at 2:23 AM | americanbankingnews.comCritical Contrast: Prenetics Global (NASDAQ:PRE) and Cytek Biosciences (NASDAQ:CTKB)February 16, 2025 | americanbankingnews.comShort Interest in Prenetics Global Limited (NASDAQ:PRE) Drops By 24.7%Prenetics Global Limited (NASDAQ:PRE - Get Free Report) was the target of a significant decrease in short interest in January. As of January 31st, there was short interest totalling 32,600 shares, a decrease of 24.7% from the January 15th total of 43,300 shares. Based on an average trading volume of 14,000 shares, the short-interest ratio is presently 2.3 days. Currently, 0.4% of the shares of the company are short sold.February 15, 2025 | marketbeat.comFinancial Comparison: Bio-Rad Laboratories (NYSE:BIO) vs. Prenetics Global (NASDAQ:PRE)February 15, 2025 | americanbankingnews.comNYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR FEBRUARY 14th + KARMAN POPS DOUBLE DIGIT IPOFebruary 14, 2025 | prnewswire.comPrenetics Global Ltd trading resumesFebruary 12, 2025 | markets.businessinsider.comPrenetics Global Ltd trading halted, volatility trading pauseFebruary 12, 2025 | markets.businessinsider.comPrenetics partners with Humanity Protocol, launches crypto strategic reserveFebruary 11, 2025 | markets.businessinsider.comPrenetics Partners with Humanity Protocol to Enhance Blockchain-Based Identity Verification and Invests in Digital AssetsFebruary 11, 2025 | quiverquant.comNasdaq-Listed Prenetics Announces Genomics-Based Partnership with Humanity Protocol and Launches Crypto Strategic ReserveFebruary 11, 2025 | globenewswire.comFY2025 Earnings Estimate for PRE Issued By Cantor FitzgeraldPrenetics Global Limited (NASDAQ:PRE - Free Report) - Equities researchers at Cantor Fitzgerald issued their FY2025 earnings estimates for shares of Prenetics Global in a report issued on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn forecasts that the company will earn ($2.08) per sJanuary 22, 2025 | marketbeat.comPrenetics Unveils IM8 to U.S. Consumers with Co-Founding Partner David BeckhamJanuary 22, 2025 | markets.businessinsider.comCantor Fitzgerald Sticks to Their Buy Rating for Prenetics Group (PRE)January 16, 2025 | markets.businessinsider.comPrenetics Global (NASDAQ:PRE) Earns Overweight Rating from Cantor FitzgeraldCantor Fitzgerald reiterated an "overweight" rating and set a $9.00 price target on shares of Prenetics Global in a research report on Thursday.January 16, 2025 | marketbeat.comPrenetics' IM8 Achieves Prestigious NSF Certified for Sport® for Daily Ultimate EssentialsJanuary 15, 2025 | globenewswire.comPrenetics Global Limited (NASDAQ:PRE) Sees Large Growth in Short InterestPrenetics Global Limited (NASDAQ:PRE - Get Free Report) was the recipient of a significant growth in short interest in December. As of December 15th, there was short interest totalling 41,900 shares, a growth of 23.6% from the November 30th total of 33,900 shares. Approximately 0.5% of the shares of the stock are short sold. Based on an average trading volume of 14,000 shares, the days-to-cover ratio is presently 3.0 days.December 31, 2024 | marketbeat.comPrenetics Global (NASDAQ:PRE) Shares Down 1.6% - Here's WhyPrenetics Global (NASDAQ:PRE) Shares Down 1.6% - Here's WhyDecember 28, 2024 | marketbeat.comPrenetics’ IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium SupplementsDecember 19, 2024 | markets.businessinsider.comPrenetics’ IM8, University of Oxford begin space experimentDecember 6, 2024 | markets.businessinsider.comPrenetics' IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications ServicesDecember 5, 2024 | globenewswire.comPrenetics Announces Participation in December Investor ConferencesDecember 4, 2024 | globenewswire.comPrenetics Global Limited: Prenetics Announces Third Quarter 2024 Financial ResultsNovember 28, 2024 | finanznachrichten.dePrenetics Global Q3 Loss Narrows On Surge In RevenueNovember 28, 2024 | markets.businessinsider.comPrenetics Announces Third Quarter 2024 Financial ResultsNovember 27, 2024 | globenewswire.comPrenetics and David Beckham launch IM8 HealthNovember 19, 2024 | markets.businessinsider.comMULTIMEDIA UPDATE -- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 HealthNovember 19, 2024 | markets.businessinsider.comDavid Beckham Wants To Replace All Your Supplements With IM8November 19, 2024 | forbes.comMULTIMEDIA UPDATE -- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 HealthNovember 18, 2024 | globenewswire.comNasdaq-Listed Prenetics and David Beckham Officially Launch IM8 HealthNovember 18, 2024 | globenewswire.comPrenetics Global And 2 Other US Penny Stocks To WatchNovember 13, 2024 | finance.yahoo.comPrenetics Announces Participation in the Sidoti Virtual Micro Cap Investor ConferenceOctober 30, 2024 | globenewswire.comPrenetics Announces Tencent’s US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer DetectionOctober 16, 2024 | finance.yahoo.comPrenetics Global Limited: Prenetics Announces Second Quarter 2024 Financial ResultsOctober 7, 2024 | finanznachrichten.dePrenetics Announces Second Quarter 2024 Financial ResultsOctober 7, 2024 | finance.yahoo.comPrenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness IndustryAugust 19, 2024 | globenewswire.comPrenetics Global Limited (NASDAQ:PRE) Short Interest UpdatePrenetics Global Limited (NASDAQ:PRE - Get Free Report) was the target of a significant decrease in short interest during the month of June. As of June 30th, there was short interest totalling 26,300 shares, a decrease of 22.6% from the June 15th total of 34,000 shares. Based on an average trading volume of 88,400 shares, the days-to-cover ratio is presently 0.3 days. Approximately 0.4% of the company's shares are short sold.July 13, 2024 | marketbeat.comPrenetics, NASDAQ Health Sciences Company, Partners with David BeckhamJuly 11, 2024 | globenewswire.comPrenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of DirectorsJuly 1, 2024 | globenewswire.comPrenetics Global Limited (NASDAQ:PRE) Sees Significant Drop in Short InterestPrenetics Global Limited (NASDAQ:PRE - Get Free Report) was the target of a significant drop in short interest during the month of June. As of June 15th, there was short interest totalling 34,000 shares, a drop of 23.8% from the May 31st total of 44,600 shares. Currently, 0.5% of the company's shares are sold short. Based on an average trading volume of 102,800 shares, the short-interest ratio is presently 0.3 days.June 29, 2024 | marketbeat.comPRE Stock Earnings: Prenetics Global Reported Results for Q1 2024June 18, 2024 | investorplace.comPrenetics Global Limited (NASDAQ:PRE) Short Interest Down 44.5% in MayPrenetics Global Limited (NASDAQ:PRE - Get Free Report) was the recipient of a large decrease in short interest in May. As of May 31st, there was short interest totalling 44,600 shares, a decrease of 44.5% from the May 15th total of 80,300 shares. Currently, 0.6% of the shares of the stock are sold short. Based on an average daily trading volume, of 113,000 shares, the short-interest ratio is presently 0.4 days.June 13, 2024 | marketbeat.comPrudential PLC Lowers Stock Holdings in Prenetics Global Limited (NASDAQ:PRE)Prudential PLC cut its holdings in shares of Prenetics Global Limited (NASDAQ:PRE - Free Report) by 93.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 684,822 shares of the company's stock after selling 9,591,997 shJune 9, 2024 | marketbeat.comPrenetics Global Limited (NASDAQ:PRE) Shares Sold by Aspex Management HK LtdAspex Management HK Ltd lessened its holdings in Prenetics Global Limited (NASDAQ:PRE - Free Report) by 93.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 346,150 shares of the company's stock afJune 8, 2024 | marketbeat.comPrenetics Global Stock (NASDAQ:PRE), Analyst Ratings, Price Targets, PredictionsApril 6, 2024 | benzinga.comPrenetics Flat on Financial ResultsApril 3, 2024 | baystreet.caPrenetics Global Limited: Prenetics Announces Fourth Quarter and Full Year 2023 Financial ResultsApril 1, 2024 | finanznachrichten.dePrenetics Global: Q4 Earnings InsightsApril 1, 2024 | benzinga.comPRE Stock Earnings: Prenetics Global Beats EPS, Misses Revenue for Q4 2023April 1, 2024 | investorplace.comPrenetics Announces Fourth Quarter and Full Year 2023 Financial ResultsApril 1, 2024 | globenewswire.comPrenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space StationFebruary 9, 2024 | finance.yahoo.com Get Prenetics Global News Delivered to You Automatically Sign up to receive the latest news and ratings for PRE and its competitors with MarketBeat's FREE daily newsletter. Email Address PRE Media Mentions By Week PRE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRE News Sentiment▼0.430.60▲Average Medical News Sentiment PRE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRE Articles This Week▼21▲PRE Articles Average Week Get Prenetics Global News Delivered to You Automatically Sign up to receive the latest news and ratings for PRE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NAUT News KEQU News FEIM News SEER News RPID News AKYA News INTT News MASS News OWLT News OPTX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRE) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prenetics Global Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Prenetics Global With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
